CYDY
CytoDyn Inc.
Key Financials
Revenue
$0
↓ 100.0%
Gross Profit
$213000
0.0%
Net Income
$-42699000
↓ 1240.2%
Operating Income
$-38575000
↓ 499.3%
EPS (Diluted)
$-0.03
↓ Infinity%
Total Assets
$14.0M
↓ 22.6%
Shareholders' Equity
$-109718000.00
↓ 14.2%
Cash & Equivalents
$11.9M
↓ 0.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 10/7/2026 | View on SEC |
| 424B3 | 10/7/2026 | View on SEC |
| EFFECT | 10/2/2026 | View on SEC |
| EFFECT | 10/2/2026 | View on SEC |
| DEF 14A | 9/28/2026 | View on SEC |
| S-3 | 9/25/2026 | View on SEC |
| POS AM | 9/25/2026 | View on SEC |
| POS AM | 9/25/2026 | View on SEC |
| 10-K | 8/31/2026 | View on SEC |
| EFFECT | 5/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYDY |
| Company Name | CytoDyn Inc. |
| CIK | 1175680 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | DE |
| Phone | 360-980-8524 |